CLINICAL AND IMMUNOLOGIC IMPORTANCE OF MDR1/PGP 170 EXPRESSION IN PATIENTS WITH BREAST CANCER

Cover Page

Cite item

Full Text

Abstract

Clinical, morphologic and immunohistochemical data of 51 patients with stage T2N1-3M0 breast cancer treated in the N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences in 2002 was analyzed. Expression of Pgp 170 was found in 19 patients. Relationship between immunophenotype of stage T2N1-3M0 breast cancer cells and main clinical and morphologic fea- tures, treatment provided and expression of multiple drug resistance gene MDR1.

About the authors

D. A. Yengay

State Institution N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow; Department of oncology of Russian Medical Academy of Post-Graduate Education, Moscow

Author for correspondence.
Russian Federation

I. V. Poddubnaya

State Institution N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow; Department of oncology of Russian Medical Academy of Post-Graduate Education, Moscow

Russian Federation

N. N. Tupitsin

State Institution N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow; Department of oncology of Russian Medical Academy of Post-Graduate Education, Moscow

Russian Federation

Ye. B. Mechetner

State Institution N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow; Department of oncology of Russian Medical Academy of Post-Graduate Education, Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2008



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.